Hypoglycaemia is reduced with use of inhaled Technosphere ® Insulin relative to insulin aspart in type 1 diabetes mellitus

Authors

E R Seaquist, University of Minnesota - Twin Cities
L Blonde, Ochsner Medical Center
J B McGill, Washington University School of Medicine in St. Louis
S R Heller, University of Sheffield
D M Kendall, MannKind Corporation
J B Bumpass, MannKind Corporation
F M Pompilio, MannKind Corporation
M L Grant, MannKind Corporation

Journal

Diabetic medicine

Publication Date

5-1-2020

Volume

37

Issue

5

First Page

752

Last Page

759

Document Type

Open Access Publication

DOI

10.1111/dme.14202

Rights and Permissions

Seaquist ER, Blonde L, McGill JB, Heller SR, Kendall DM, Bumpass JB, Pompilio FM, Grant ML. Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus. Diabet Med. 2020 May;37(5):752-759. doi: 10.1111/dme.14202. © 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

Recommended Citation

Seaquist, E R; Blonde, L; McGill, J B; Heller, S R; Kendall, D M; Bumpass, J B; Pompilio, F M; and Grant, M L, "Hypoglycaemia is reduced with use of inhaled Technosphere ® Insulin relative to insulin aspart in type 1 diabetes mellitus." Diabetic medicine. 37, 5. 752 - 759. (2020).
https://digitalcommons.wustl.edu/oa_4/1451

Department

ICTS (Institute of Clinical and Translational Sciences)